IMARC Group’s report titled "Aortic Valve Replacement Market Report by Surgery (Open Surgery, Minimally Invasive Surgery), Product (Transcatheter Aortic Valve, Sutureless Valve, and Others), End Use (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2025-2033". The global aortic valve replacement market size reached USD 11.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 26.8 Billion by 2033, exhibiting a growth rate (CAGR) of 9.62% during 2025-2033.

Factors Affecting the Growth of the Aortic Valve Replacement Industry:

• Technological Advancements in Surgical Techniques:

Technavio; Technological advancement in surgery including MI surgery and Transcatheter surgery is boosting the market. These can be less radical to the conventional method of an operation that requires opening the chest cavity and stapling the heart. These innovations are more likely to provide treatment to the patients. Furthermore, better accuracy and results of these methods make a patient satisfied and the result clinical effectiveness. Moreover, the mentioned state-of-the-art methods are being integrated into healthcare practice more often because of their efficiency. Besides this, the gradual increasing awareness towards better patient care motivation is also boosting the market.   

• Rising Demand for Transcatheter Aortic Valve Replacement (TAVR) Procedures:

TAVR especially useful in high risk or elderly patients. It is an MI nature and has the better prognosis than conventionally perform operation. The growth of TAVR market is driven by higher TAVR procedure preferences resulting in shorter recovery time, shorter hospital stays, and higher survival rates on implantation. Other than this, the patients and healthcare providers are using TAVR as a safe and efficient procedure for the treatment which is driving the market forward. Moreover, sustained technological upgradations and increasing application of the TAVR make the sphere of aortic valve therapy promising and robust.  

• Increasing Healthcare Expenditure:

Increased demand of aortic valve replacement associated with the growing healthcare expenditure in developed countries is fuelling the market growth. There has been increased reveal of patients to enhanced treatment, such as aortic valve replacement due to enhanced access to improved health facilities. Further, funds can enhance acquisition of appropriate technologies and other technologies to support quality health care delivery. Apart from this, a rise in these. health expenditures improves patients’ ability to afford as well as receive AVR procedures. High expenditure in the healthcare sector not only enhances the research and development (R & D) hence constant innovation of therapies in AVR.

Grab a sample PDF of this report: https://www.imarcgroup.com/aortic-valve-replacement-market/requestsample

Leading Companies Operating in the Global Aortic Valve Replacement Industry:

• Abbott Laboratories
• Anteris Technologies Ltd.
• Boston Scientific Corporation
• Coroneo Inc.
• CryoLife Inc.
• Edward Lifesciences Corporation
• JenaValve Technology Inc.
• LifeNet Health Inc.
• LivaNova PLC
• Medtronic plc
• Thubrikar Aortic Valve Inc

Aortic Valve Replacement Market Report Segmentation:

By Surgery:

• Open Surgery
• Minimally Invasive Surgery

Minimally invasive surgery represents the largest segment as it offers advantages over traditional open-heart surgery, including smaller incisions, reduced trauma to surrounding tissues, and shorter recovery times.

By Product:

• Transcatheter Aortic Valve
• Sutureless Valve
• Others

Transcatheter aortic valve holds the biggest market share due to its less invasive nature.    

By End Use:

• Hospitals
• Ambulatory Surgery Centers
• Others

Hospitals account for the largest market share, driven by centralized healthcare delivery.  

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys a leading position in the aortic valve replacement market on account of the presence of highly developed healthcare infrastructure, including state-of-the-art hospitals, specialized cardiovascular centers, and advanced medical technologies.    

Global Aortic Valve Replacement Market Trends:

Increasing awareness about heart valve diseases and treatment options is fueling the market growth. Public education initiatives, coupled with improved patient awareness, encourage early identification and timely intervention for aortic valve disorders. Individuals are becoming more informed about the symptoms and consequences of aortic valve diseases and are seeking better medical advice. In addition, healthcare professionals are focusing on identifying at-risk patients, recommending appropriate interventions, and improving patient outcomes.

The elderly population is more prone to age-related cardiovascular conditions, including aortic valve diseases, which is catalyzing the demand for aortic valve replacement.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
 

Contact US

 IMARC Group
 134 N 4th St. Brooklyn, NY 11249, USA
 Email: sales@imarcgroup.com
 Tel No:(D) +91 120 433 0800
 United States: +1-631-791-1145